Gastric secretion

Current Opinion in Gastroenterology

Volumn 29, Issue 6, 2013, Pages 636-641

  Chu, Shijian ^a   Schubert, Mitchell L ^a,b  

^a McGuire Veterans Affairs Medical Center ^*  (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acid; gastrin; H+K + ATPase; Helicobacter pylori; histamine

Indexed keywords

ACETYLCHOLINE; ADENYLATE CYCLASE; CALCITONIN GENE RELATED PEPTIDE; CALCIUM; CARBOXYPEPTIDASE H; CHOLECYSTOKININ; CHROMOGRANIN A; CRE RECOMBINASE; CYANOCOBALAMIN; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; GASTRIN; GHRELIN; GLUCAGON; GLUCOSE; GLUTAMINE; HISTAMINE; INSULIN; INTERLEUKIN 11; IRON; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PANCREASTATIN; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KCNQ1; PROGASTRIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; SOMATOSTATIN; UROCORTIN I;

ACHLORHYDRIA; BACTERIAL OVERGROWTH; BACTERIAL PERITONITIS; CELL MIGRATION; CELL PROLIFERATION; DUODENUM ULCER; ENDOPLASMIC RETICULUM; FOOD INTAKE; GASTRIN BLOOD LEVEL; GASTRIN RELEASE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL STROMAL TUMOR; GOLGI COMPLEX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HYPERGASTRINEMIA; INFECTION; INTESTINE ABSORPTION; INTESTINE INFECTION; NEUROENDOCRINE SYSTEM; PATHOGENICITY ISLAND; PEPTIC ULCER; PH; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; STOMACH ACID; STOMACH ACID SECRETION; STOMACH ANTRUM; STOMACH EMPTYING; STOMACH MUCUS; STOMACH SECRETION; TYPE IV SECRETION SYSTEM;

GASTRIC ACID; GASTRINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE; HUMANS; NEUROSECRETORY SYSTEMS; PARIETAL CELLS, GASTRIC;

EID: 84886093003     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328365efc7     Document Type: Review

References (44)

1. Fossmark R, Waldum H. The distressing overuse of gastric acid inhibitors. Dig Dis Sci 2013; 58:600-601.
2. Goel GA, Deshpande A, Lopez R, et al. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression. Clin Gastroenterol Hepatol 2012; 10:422-427.
3. Heidelbaugh JJ, Kim AH, Chang R, Walker PC. Overutilizationof proton-pump inhibitors: what the clinician needs to know. Ther Adv Gastroenterol 2012; 5:219-232.
4. Mitrovic O, Micic M, Radenkovic G, et al. Endocrine cells in human fetal corpus of stomach: appearance, distribution, and density. J Gastrenterol 2012; 47:1212-1220.
5. Tuo B, Ju Z, Riederer B, et al. Telomere shortening is associated with reduced duodenal HCO3-secretory but normal gastric acid secretory capacity in aging mice. Am J Physiol Gastrointest Liver Physiol 2012; 303:G1312-G1321.
6. Bitziou E, Patel BA. Simultaneous detection of gastric acid and histamine release to unravel the regulation of acid secretion from the guinea pig stomach. Am J Physiol Gastrointest Liver Physiol 2012; 303:G396-G403.
7. Zhao C-M, Chen D. The ECL cell: relay station for gastric integrity. Curr Medicinal Chem 2012; 19:98-108.
8. Walker AK, Park WM, Chuang J-C, et al. Characterization of gastric and neuronal histaminergic populations using a transgenic mouse model. PLoS One 2013; 8:e60276.
9. Hunyady B, Zólyomi A, Hoffman BJ, Mezey É. Gastrin-producing endocrine cells: a novel source of histamine in the rat stomach. Endocrinology 1998; 139:4404-4415. (Pubitemid 28513731)
10. Cockburn AN, Morgan CJ, Genta RM. Neuroendocrine proliferations of the stomach: a pragmatic approach for the perplexed pathologist. Adv Anat Pathol 2013; 20:148-157.
11. Chueca E, Lanas A, Piazuelo E. Role of gastrin-peptides in Barrett's and colorectal carcinogenesis. World J Gastroenterol 2012; 18:6560-6570.
12. Treem W, Hu P, Sloan S. Normal and proton pump inhibitor-mediated gastrin levels in infants 1-11 months. Pharmacol Ther 2012; 35:368-379.
13. Dockray GJ, Moore A, Varro A, Pritchard DM. Gastrin receptor pharmacology. Curr Gastroenterol Rep 2012; 14:453-459.
14. Boyce M, Warrington S. Effect of repeated doses of netazepide, a gastrin receptor anagonist, omeprazole and placebo on 24-h gastric acidity and gastrin in healthy subjects. Br J Pharmacol 2013.
15. Barrett TD, Lagaud G, Wagaman P, et al. The cholecystokinin CCK2 receptor antagonist, JNJ-26070109, inhibits gastric acid secretion and prevents omeprazole-induced acid rebound in the rat. Br J Pharmacol 2012; 166: 1684-1693.
16. Jianu CS, Fossmark R, Viset T, et al. Gastric carcinoids after long-term use of a proton pump inhibitor. Aliment Pharmacol Ther 2012; 36:644-649.
17. Crosby DA, Donohoe CL, Fitzgerald L, et al. Gastric neuroendocrine tumours. Dig Surg 2012; 29:331-348.
18. Fossmark R, Sordal O, Jianu CS, et al. Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A. Aliment Pharmacol Ther 2012; 36:1067-1075.
19. McCarthy DM. Commentary: a gastrin antagonist against carcinoids: implications for PPI-induced hypergastrinemia. Aliment Pharmacol Ther 2013; 37:276-277.
20. Quattrone A, Dewaele B, Wozniak A, et al. Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis. J Pathol 2012; 228:565-574.
21. Steigedal TS, Prestvik WS, Selvik LM, et al. Gastrin-induced proliferation involves MEK partner 1 (MP1). In Vitro Cell Dev Biol 2013; 49:162-169.
22. Ziao L, Kovak S, Chang M, et al. Induction of gastrin expression in gastrointestinal cells by hypoxia or cobalt is independent of hypoxia-inducible factor (HIF). Endocrinology 2012; 153:3006-3016.
23. Tsuji S, Sun WH, Tsujii M, et al. Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats. J Pharmacol Exp Ther 2002; 303:1301-1308. (Pubitemid 35424417)
24. Takamura A, Ito M, Boda T, et al. High expression of gastrin receptor protein in injured mucosa of Helicobacter pylori-positive gastritis. Dig Dis Sci 2012; 58:634-640.
25. Brennan IM, Luscombe-Marsh ND, Seimon RV, et al. Effects of fat, protein, and carbohydrate and protein load on appetite, plasma cholecystokinin, peptide YY, and ghrelin, and energy intake in lean and obese men. Am J Physiol Gastrointest Liver Physiol 2012; 303:G129-G140.
26. Deng ZH, Chu B, Xu YZ, et al. Influence of Helicobacter pylori infection on ghrelin levels in children. World J Gastroenterol 2012; 18:5096-5100.
27. Sakata I, Park WM, Walker AK, et al. Glucose-mediated control of ghrelin release from primary cultures of gastric mucosal cells. Am J Physiol Endocrinol Metab 2012; 302:E1300-E1310.
28. Takiguchi S, Adachi S, Yamamoto K, et al. Mapping analysis of ghrelin producing cells in the human stomach associated with chronic gastritis and early cancers. Dig Dis Sci 2012; 57:1238-1246.
29. Gagnon J, Anini Y. Glucagon stimulates ghrelin secretion through the activation of MAPK and EPAC and potentiates the effect of norepinephrine. Endocrinology 2013; 154:666-674.
30. Xia ZF, Fritze DM, Li J-L, et al. Nesfatin-1 inhibits gastric acid secretion via a central vagal mechanism in rats. Am J Physiol Gastrointest Liver Physiol 2012; 303:G570-G577.
31. Howlett M, Chalinor HV, Buzzelli JN, et al. IL-11 is a parietal cell cytokine that induces atrophic gastritis. Gut 2012; 61:1398-1409.
32. Barwell J, Woolley MJ, Wheatley M, et al. The role of extracellular loops of the CGRP receptor, a family B GPCR. Biochem Soc Trans 2012; 40:433-437.
33. Zaki M, Coudron PE, McCuen RW, et al. H. pylori acutely inhibits gastric secretion by activating CGRP sensory neurons coupled to stimulation of somatostatin and inhibition of histamine secretion. Am J Physiol Gastrointest Liver Physiol 2013; 304:G715-G722.
34. Egea SC, Dickerson IM. Direct interactions between calcitonin-like receptor (CLR) and CGRP-receptor component protein (RCP) regulate CGRP receptor signaling. Endocrinology 2012; 153:1850-1860.
35. Bucker R, Azevedo-Vethacke M, Groll C, et al. Helicobacter pylori colonization critically depends on postprandial gastric conditions. Scientific Rep 2012; 2:1-10.
36. Cover TL. Role of Helicobacter pylori CagL in modulating gastrin secretion. Gut 2012; 1:965-966.
37. 5-integrin- integrin linked kinase signalling complex. Gut 2012; 61:986-996.
38. Marcus EA, Inatomi N, Nagami GT, et al. The effects of varying acidity on Helicobacter pylori growth and the bactericidal efficacy of ampicillin. Aliment Pharmacol Ther 2012; 36:972-979.
39. Durr KL, Tavraz NN, Friedrich T. Control of gastric H, K-ATPase activity by cations, voltage and intracellular pH analyzed by voltage clamp fluorometry in xenopus oocytes. PLoS One 2012; 7:e33645.
40. +-ATPase is a monomer. J Biol Chem 2012; 287:41963-41978.
41. Fiocca R, Mastracci L, Attwood SE, et al. Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial. Aliment Pharmacol Ther 2012; 36:959-971.
42. Loh YP, Cheng Y, Mahata SK, et al. Chromogranin A and derived peptides in health and disease. J Mol Neurosci 2012; 48:347-356.
43. Mosli HH, Dennis A, Kocha W, et al. Effect of short-term proton pump inhibitor treatment and its discontinuation on chromogranin A in healthy subjects. J Clin Endocrinol Metab 2012; 97:E1731-E1735.
44. +-ATPase in gastric parietal cells from mice. Am J Physiol Gastrointest Liver Physiol 2012; 304:G157-G166.